Drug Type Small molecule drug |
Synonyms PELA-1267 |
Target |
Action inhibitors |
Mechanism NLRP3 inhibitors(NACHT, LRR and PYD domains-containing protein 3 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Discovery | United States | - | |
Coronary Artery Disease | Discovery | United States | - | |
Gout | Discovery | United States | - | |
Inflammation | Discovery | United States | - | |
Multiple Sclerosis | Discovery | United States | - | |
Parkinson Disease | Discovery | United States | - | |
Rheumatoid Arthritis | Discovery | United States | - |